n = 4 | Genes associated with this histologic typeb | |||||
Age | APC | P16 | ||||
Range | 13–40 | FHIT | PTEN | |||
Mean | 29 | FGFR1 | RB | |||
Median | 32 | KRAS | SOX | |||
BMI | MCC | TP53 | ||||
Range | 21.5–39.5 | MEN-2 | ||||
Mean | 29.1 | MYCL | ||||
Median | 27.7 | |||||
Survival | ||||||
Range | 189–596 | |||||
Mean | 366 | |||||
Median | 339.5 | |||||
Chemo | Rad | Alive | Novel Targets | Profiles | ||
Location | ||||||
Ovary | 2 (50%) | Plat/Etoposide | 0 | 1 (50%) |
AKAP9 (1) ASXL1 (1) MBD1 (1) ALK (1) GPR124 (1) KMT2D (1) |
AKAP9, ASXL1, MBD1 (1) ALK, GPR124, KMT2D (1)a |
Cervix | 1 (25%) | Plat/Etoposide | 1 | 1 (100%) |
AKAP9 (1) ASXL1 (1) CMPK1 (1) | AKAP9, ASXL1, CMPK1 (1) |
Endometrial | 1 (25%) | Carbo/Taxol | 1 | 0 (0%) |
ROS1 (1) ALK (1) ERBB3 (1) GPR124 (1) KMT2D (1) NTRK1 (1) | ROS1, ALK, ERBB3, GPR124, KMT2D, NTRK1 (1)a |